모바일 헬스(mHealth) 시장 : 제공 형태, 도입 모델, 용도, 최종사용자, 판매채널별 - 세계 시장 예측(2026-2032년)

The mHealth Market is projected to grow by USD 314.55 billion at a CAGR of 16.29% by 2032.

mHealth, or mobile health, has moved from a consumer wellness category into a core layer of digital health infrastructure. The market includes mobile medical apps, remote patient monitoring, connected wearables, medication adherence tools, telehealth-enabled smartphones, and secure patient engagement platforms used by providers, payers, pharmaceutical companies, and public health agencies.

Demand is supported by measurable structural drivers: widespread smartphone adoption, aging populations, chronic disease prevalence, and pressure to expand care access outside hospitals. The World Health Organization and World Bank reported that at least 4.5 billion people were not fully covered by essential health services in 2021, while GSMA reported 5.6 billion unique mobile subscribers globally by the end of 2023. This creates a practical foundation for mobile-first healthcare delivery, especially where physical health infrastructure is constrained.

Transformative Shifts in the mHealth Landscape

The mHealth landscape is being reshaped by the shift from episodic care to continuous, data-enabled care. Hospitals and health systems are extending clinical workflows into homes through app-based triage, remote monitoring, and connected devices that help manage diabetes, cardiovascular disease, respiratory conditions, maternal health, and behavioral health.

Regulation is also becoming more mature. Authorities such as the U.S. FDA, European regulators under MDR, and national digital health agencies are clarifying requirements for software as a medical device, cybersecurity, clinical validation, and data privacy. This is raising barriers for low-quality apps while improving trust in clinically supported mHealth platforms.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is increasing the cumulative value of mHealth by turning mobile data streams into earlier signals, personalized interventions, and automated clinical support. AI-enabled symptom checkers, risk stratification tools, medication reminders, imaging support, and digital therapeutics can improve scalability when they are clinically validated and integrated into care pathways.

The impact is strongest where AI supports clinicians rather than replacing them. In mHealth, responsible AI requires transparent model governance, representative datasets, bias monitoring, patient consent, and compliance with health data regulations such as HIPAA, GDPR, and emerging AI rules. As adoption grows, competitive advantage will depend on evidence generation, explainability, interoperability, and measurable outcomes.

Key Regional Insights: Asia-Pacific, North America, Europe, Latin America, Middle East, and Africa

Asia-Pacific is one of the most dynamic mHealth regions due to large mobile-first populations, expanding 5G coverage, and government-backed digital health programs in China, India, Japan, South Korea, Australia, and ASEAN markets. India's Ayushman Bharat Digital Mission and China's digital hospital ecosystem illustrate how mobile platforms are becoming part of national health infrastructure, while Japan, South Korea, and Australia are using connected care to address aging populations, rural access, and advanced digital service delivery.

North America remains a leading commercialization region, supported by high smartphone penetration, advanced reimbursement models, remote patient monitoring adoption, and strong regulatory pathways for mobile medical applications. Europe emphasizes regulated, interoperable, privacy-led deployment under GDPR, the Medical Device Regulation, and national digital health reimbursement frameworks. Latin America shows rising demand for mobile-enabled primary care and chronic disease support, especially in Brazil and Mexico, where mobile connectivity helps extend services across urban and underserved communities. The Middle East is advancing mHealth through national digital transformation strategies in the GCC, smart hospital initiatives, and connected public health platforms, while Africa's opportunity is defined by mobile-first access, public health messaging, maternal health, community-based care models, and the ability of mobile networks to reach populations beyond traditional facility-based systems.

Key Group Insights: ASEAN, GCC, European Union, BRICS, G7, and NATO

ASEAN markets are expanding mHealth through mobile payments, super-app ecosystems, teleconsultation platforms, and government digital health initiatives, although interoperability and cross-border data governance remain uneven across member states. The GCC is investing heavily in virtual care, national health data platforms, smart hospital programs, and digital identity systems, making mHealth a key component of healthcare modernization and preventive care strategies.

The European Union is shaping mHealth through GDPR, MDR, the European Health Data Space, cybersecurity requirements, and digital identity initiatives that favor secure data exchange and validated digital tools. BRICS economies create scale through large populations, rising chronic disease burdens, and public health needs, with China and India especially important for mobile-first volume adoption and national digital health infrastructure. G7 countries lead in reimbursement maturity, regulatory scrutiny, clinical evidence requirements, and AI governance discussions, while NATO countries increasingly view cyber-resilient health infrastructure, secure health data exchange, and continuity of care during emergencies as part of national resilience.

Key Country Insights Across Major mHealth Markets

The United States leads in remote patient monitoring, digital therapeutics, payer-led virtual care, and FDA-regulated mobile medical applications, supported by established telehealth use and reimbursement mechanisms. Canada emphasizes equitable access, privacy, and provincial digital health integration, with mHealth increasingly relevant for rural and remote communities. Mexico and Brazil show growing mHealth demand for primary care access, chronic disease management, pharmacy-connected services, and mobile-enabled care navigation in large, diverse populations.

In Europe, the United Kingdom is advancing digital access through national health service channels and remote consultation models, Germany supports reimbursable digital health applications through its DiGA pathway, France is strengthening digital health reimbursement and data governance, and Italy and Spain are expanding regional telehealth, electronic health records, and patient engagement programs. Russia maintains domestic digital health capabilities and telemedicine development amid changing technology procurement patterns and a stronger focus on local infrastructure.

In Asia-Pacific, China has scaled mobile health through platform ecosystems, online hospitals, and digital hospital services, while India is building national digital health rails through digital health IDs, registries, and interoperable health records. Japan prioritizes aging-related remote care and connected monitoring, South Korea combines advanced connectivity with digital health innovation and strong broadband infrastructure, and Australia supports telehealth, rural access, e-prescriptions, and connected care under a mature regulatory environment.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated mHealth solutions that solve measurable care gaps, such as medication adherence, chronic disease monitoring, behavioral health access, maternal care, remote triage, and post-discharge follow-up. Products should be designed for integration with electronic health records, payer workflows, pharmacy networks, medical devices, and clinician dashboards rather than operating as isolated consumer apps.

Executives should invest early in cybersecurity, privacy-by-design, accessibility, multilingual support, regulatory evidence, and real-world performance measurement. Partnerships with providers, payers, medical device manufacturers, telecom operators, public health agencies, and community care networks can accelerate adoption. The strongest strategies will combine user-friendly mobile experiences with outcomes data, reimbursement readiness, interoperable cloud architecture, and responsible AI governance.

Research Methodology

This executive summary is based on secondary research and industry triangulation using publicly available information from government health agencies, regulators, multilateral organizations, telecom industry bodies, clinical guidance sources, peer-reviewed literature, and official digital health program documentation. Key reference points include WHO and World Bank universal health coverage reporting, GSMA mobile adoption data, FDA digital health guidance, GDPR and EU medical device frameworks, and national digital health programs.

The methodology emphasizes data-backed interpretation rather than speculative assumptions. Insights were evaluated across technology adoption, regulatory maturity, healthcare access needs, reimbursement signals, demographic trends, chronic disease burden, cybersecurity requirements, and digital infrastructure readiness to identify the most relevant mHealth growth patterns by region, group, and country.

Conclusion: The Future of Mobile Health

mHealth is becoming a critical bridge between digital infrastructure and healthcare delivery. Its strongest value lies in extending care beyond physical facilities, improving patient engagement, supporting chronic disease management, strengthening public health outreach, and enabling earlier intervention through connected data.

The next phase of market leadership will be defined by trust, evidence, interoperability, cybersecurity, and responsible AI. Organizations that can demonstrate clinical impact, protect sensitive health data, integrate with healthcare workflows, and adapt to regional regulatory expectations will be best positioned to capture long-term growth in the global mHealth ecosystem.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. mHealth Market, by Offering

• 7.1. Connected Medical Devices
  • 7.1.1. Blood Glucose Meters
  • 7.1.2. Blood Pressure Monitors
  • 7.1.3. ECG/Heart Rate Monitors
  • 7.1.4. Fetal Monitoring Devices
  • 7.1.5. Neurological Monitoring Devices
  • 7.1.6. Peak Flowmeters
  • 7.1.7. Pulse Oximeters
  • 7.1.8. Sleep Apnea Monitors
• 7.2. Wearable Devices
  • 7.2.1. Fitness Trackers
  • 7.2.2. Smart Watches
• 7.3. mHealth Apps
  • 7.3.1. Chronic Disease Management Apps
  • 7.3.2. Medication Management Apps
  • 7.3.3. Personal Health Record Apps
• 7.4. mHealth Services
  • 7.4.1. Diagnosis & Consultation Services
  • 7.4.2. Fitness & Wellness Services
  • 7.4.3. Prevention Services
  • 7.4.4. Remote Monitoring Services
  • 7.4.5. Treatment Services

8. mHealth Market, by Deployment Model

• 8.1. Standalone
• 8.2. Integrated

9. mHealth Market, by Application

• 9.1. Chronic Disease Management
  • 9.1.1. Asthma Management
  • 9.1.2. Cardiovascular Disease Management
  • 9.1.3. Diabetes Management
• 9.2. General Health & Fitness
• 9.3. Remote Consultation & Telemedicine
• 9.4. Women's Health
  • 9.4.1. Menopause Management
  • 9.4.2. Menstrual Health
  • 9.4.3. Pregnancy Tracking

10. mHealth Market, by End-User

• 10.1. Healthcare Payers
• 10.2. Healthcare Providers
  • 10.2.1. Clinics
  • 10.2.2. Hospitals
• 10.3. Patients

11. mHealth Market, by Sales Channel

• 11.1. Direct Sales
• 11.2. Distributor Sales
• 11.3. Online Sales

12. mHealth Market, by Region

• 12.1. Asia-Pacific
• 12.2. North America
• 12.3. Latin America
• 12.4. Europe
• 12.5. Middle East
• 12.6. Africa

13. mHealth Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. mHealth Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. Competitive Landscape

• 15.1. Market Concentration Analysis, 2025
  • 15.1.1. Concentration Ratio (CR)
  • 15.1.2. Herfindahl Hirschman Index (HHI)
• 15.2. Recent Developments & Impact Analysis, 2025
• 15.3. Product Portfolio Analysis, 2025
• 15.4. Benchmarking Analysis, 2025

16. Company Profiles

• 16.1. Abbott Laboratories
• 16.2. AgaMatrix Inc.
• 16.3. AirStrip Technologies, Inc.
• 16.4. Akili Inc.
• 16.5. AliveCor, Inc.
• 16.6. Amazon Web Services, Inc.
• 16.7. Apple Inc.
• 16.8. AT&T Inc.
• 16.9. Biofourmis Inc.
• 16.10. Boston Scientific Corporation
• 16.11. Cisco Systems, Inc.
• 16.12. Cognoa, Inc.
• 16.13. Dexcom, Inc.
• 16.14. eMed Healthcare UK Ltd.
• 16.15. F. Hoffmann-La Roche Ltd.
• 16.16. Garmin Ltd.
• 16.17. Google LLC by Alphabet Inc.
• 16.18. Huawei Technologies Co., Ltd.
• 16.19. iHealth Lab Inc.
• 16.20. International Business Machines Corporation
• 16.21. Johnson & Johnson Services, Inc.
• 16.22. Koninklijke Philips N.V.
• 16.23. Lumeon Ltd.
• 16.24. Medisafe Project Ltd.
• 16.25. Medtronic PLC
• 16.26. OMRON HEALTHCARE , INC
• 16.27. Oracle Corporation
• 16.28. Qualcomm Technologies, Inc.
• 16.29. ResMed Inc.
• 16.30. Samsung Electronics Co., Ltd.
• 16.31. Teladoc Health
• 16.32. Xiaomi Corp.